Clinical Trial: Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer

U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07645391) titled 'Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer' on June 08.

Brief Summary: This study evaluates urinary biomarkers and PSA to help determine the best approach to early detection of prostate cancer in patients with an elevated familial risk.

Study Start Date: Jan. 01, 2017

Study Type: OBSERVATIONAL

Condition: Prostate Carcinoma

Intervention: OTHER: Non-Interventional Study

Non-interventional study

Recruitment Status: RECRUITING

Sponsor: University of Michigan Rogel Cancer Center

Published by HT Digital Content Services with permission from Health Daily Digest....